Olema Pharmaceuticals, Inc. (OLMA)
24.34
+0.91
(+3.88%)
USD |
NASDAQ |
Mar 04, 16:00
24.31
-0.03
(-0.12%)
After-Hours: 20:00
Olema Pharmaceuticals Research and Development Expense (Annual) : 124.52M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cogent Biosciences, Inc. | 265.16M |
| Corvus Pharmaceuticals, Inc. | 19.38M |
| Protagonist Therapeutics, Inc. | 159.29M |
| BridgeBio Pharma, Inc. | 451.95M |
| Oric Pharmaceuticals, Inc. | 109.82M |